OTV

Scopio Labs Ltd., founded in 2015 and based in Tel Aviv, Israel, specializes in the development of advanced digital microscopes that utilize computational imaging technology. The company focuses on enhancing hematology diagnostics by providing tools that allow for high-resolution imaging of blood samples and bone marrow aspirates. Scopio Labs' solutions aim to improve the efficiency and accuracy of diagnosing blood-related diseases by enabling laboratories to analyze cell morphology at scale. Their offerings cater to various applications, including cancer screening, cytology, academic research, and drug discovery, thus unlocking actionable insights from complex datasets in clinical settings.

TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.

Medasense is a company specializing in pain monitoring technology aimed at optimizing and personalizing pain management for patients. Its flagship product, the PMD-200, utilizes a proprietary non-invasive sensor platform and artificial intelligence to objectively monitor and quantify a patient's pain response through the NOL® index. This device is particularly beneficial in operating rooms and critical care settings where patients cannot communicate, addressing a significant market need. Medasense also offers pipeline cloud-based solutions that leverage NOL technology for use in clinics and home care, targeting an even larger global market. The PMD-200 is distributed in Europe by Medtronic and has received clearance for marketing in Canada, Latin America, and Australia, with capabilities for integration with Philips patient monitors. Clinical studies have highlighted its effectiveness in improving patient safety and outcomes while reducing opioid usage. Founded in 2008, Medasense is headquartered in Ramat Gan, Tel Aviv, Israel.

Scopio Labs Ltd., founded in 2015 and based in Tel Aviv, Israel, specializes in the development of advanced digital microscopes that utilize computational imaging technology. The company focuses on enhancing hematology diagnostics by providing tools that allow for high-resolution imaging of blood samples and bone marrow aspirates. Scopio Labs' solutions aim to improve the efficiency and accuracy of diagnosing blood-related diseases by enabling laboratories to analyze cell morphology at scale. Their offerings cater to various applications, including cancer screening, cytology, academic research, and drug discovery, thus unlocking actionable insights from complex datasets in clinical settings.

TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.

HARBO Technologies Ltd. specializes in solutions for preventing the severe consequences of oil spills through its innovative T-Fence immediate booming system. Founded in 2012 and based in Tel Aviv, Israel, the company has developed a lightweight and efficient oil spill response mechanism that can be deployed by as few as two personnel at the spill source, making it suitable for use on vessels, at ports, or oil terminals. The T-Fence system features a compact vessel that simultaneously produces and deploys an offshore containment boom, effectively blocking the spread of oil spills in various challenging environments. HARBO Technologies aims to serve a diverse range of clients, including oil companies, coast guard units, and marine agriculture sectors, by providing a rapid response solution that minimizes environmental damage and reduces logistical complexities.

Gauzy, established in 2009, is a global leader in light control glass technology. Headquartered in Tel Aviv, Israel, with operations in the US and Germany, the company specializes in developing, manufacturing, and marketing LCG® (light control glass) technology. Gauzy's innovative products, including SPD and PDLC films, enable glass to transition from transparent to varying degrees of opacity, offering custom shading, solar control, and transparent displays. Their solutions are used in diverse applications such as architecture, automotive, aviation, and consumer electronics, serving global brands like Crowne Plaza, Deloitte, and The Ritz Carlton. Gauzy's global presence includes dedicated production facilities, R&D centers, sales offices, and a network of certified partners, bringing its technology to over 40 countries.

Scopio Labs Ltd., founded in 2015 and based in Tel Aviv, Israel, specializes in the development of advanced digital microscopes that utilize computational imaging technology. The company focuses on enhancing hematology diagnostics by providing tools that allow for high-resolution imaging of blood samples and bone marrow aspirates. Scopio Labs' solutions aim to improve the efficiency and accuracy of diagnosing blood-related diseases by enabling laboratories to analyze cell morphology at scale. Their offerings cater to various applications, including cancer screening, cytology, academic research, and drug discovery, thus unlocking actionable insights from complex datasets in clinical settings.

Medasense is a company specializing in pain monitoring technology aimed at optimizing and personalizing pain management for patients. Its flagship product, the PMD-200, utilizes a proprietary non-invasive sensor platform and artificial intelligence to objectively monitor and quantify a patient's pain response through the NOL® index. This device is particularly beneficial in operating rooms and critical care settings where patients cannot communicate, addressing a significant market need. Medasense also offers pipeline cloud-based solutions that leverage NOL technology for use in clinics and home care, targeting an even larger global market. The PMD-200 is distributed in Europe by Medtronic and has received clearance for marketing in Canada, Latin America, and Australia, with capabilities for integration with Philips patient monitors. Clinical studies have highlighted its effectiveness in improving patient safety and outcomes while reducing opioid usage. Founded in 2008, Medasense is headquartered in Ramat Gan, Tel Aviv, Israel.

HARBO Technologies Ltd. specializes in solutions for preventing the severe consequences of oil spills through its innovative T-Fence immediate booming system. Founded in 2012 and based in Tel Aviv, Israel, the company has developed a lightweight and efficient oil spill response mechanism that can be deployed by as few as two personnel at the spill source, making it suitable for use on vessels, at ports, or oil terminals. The T-Fence system features a compact vessel that simultaneously produces and deploys an offshore containment boom, effectively blocking the spread of oil spills in various challenging environments. HARBO Technologies aims to serve a diverse range of clients, including oil companies, coast guard units, and marine agriculture sectors, by providing a rapid response solution that minimizes environmental damage and reduces logistical complexities.

Via Surgical Ltd. specializes in developing innovative surgical fixation technologies aimed at enhancing hernia repair procedures. Founded in 2011 and based in Amirim, Israel, the company has created FasTouch, a system that facilitates the deployable fixation of sutures, ensuring strong and consistent support during surgical interventions. The design of these lightweight sutures incorporates a closed locked-loop concept, which not only provides effective fixation but also minimizes the amount of material used, potentially reducing foreign body reactions and chronic pain in patients. Via Surgical's offerings extend beyond hernia repair, also encompassing applications in rotator cuff repair using minimally invasive techniques. The founding team, with prior experience at PolyTouch Medical, is committed to advancing soft tissue repair technologies.

Scopio Labs Ltd., founded in 2015 and based in Tel Aviv, Israel, specializes in the development of advanced digital microscopes that utilize computational imaging technology. The company focuses on enhancing hematology diagnostics by providing tools that allow for high-resolution imaging of blood samples and bone marrow aspirates. Scopio Labs' solutions aim to improve the efficiency and accuracy of diagnosing blood-related diseases by enabling laboratories to analyze cell morphology at scale. Their offerings cater to various applications, including cancer screening, cytology, academic research, and drug discovery, thus unlocking actionable insights from complex datasets in clinical settings.